Assignee
MODALIS THERAPEUTICS CORP
JP·3 granted patents·5 pending applications·0 citations·filing 2018–2021
Top patents by PatentIndex Score
8 records- 0151US2023323456A1Method for treating facioscapulohumeral muscular dystrophy (fshd) by targeting dux4 geneMODALIS THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 0250US12502418B2Method for treating muscular dystrophy by targeting LAMA1 geneMODALIS THERAPEUTICS CORP·Filed 2020·Granted Dec 23, 2025·0 cites·13 claims
- 0343US11439692B2Method of treating diseases associated with MYD88 pathways using CRISPR-GNDM systemMODALIS THERAPEUTICS CORP·Filed 2018·Granted Sep 13, 2022·0 cites·17 claims
- 0443US2023248810A1Method for treating alzheimer's disease by targeting mapt geneMODALIS THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 0542US2021246473A1Modified cas9 protein, and use thereofMODALIS THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 0641US2021332094A1Novel transcription activatorMODALIS THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 0740US11591621B2Method of treating diseases associated with elevated KRAS expression using CRISPR-GNDM systemMODALIS THERAPEUTICS CORP·Filed 2018·Granted Feb 28, 2023·0 cites·8 claims
- 0840US2022017881A1MODIFIED Cas9 PROTEIN AND USE THEREOFMODALIS THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →